Assessment of long-term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971-1975: Results of a pilot study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 3, 1999, Pages 269-273

  Rodger, Alison J ^a   Thomson, Jennifer A ^b   Thompson, Sandra C ^b   Jolley, Damien ^b   Mijch, Anne M ^b   Lanigan, Anna ^b   Crofts, Nick ^b  

^a MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH   (Australia)

^b NONE

Author keywords

Hepatitis C virus; Injecting drug use; Liver disease; Retrospective cohort

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS C ANTIBODY; ILLICIT DRUG;

ACUTE HEPATITIS; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CHRONIC HEPATITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE;

EID: 0032923012     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01846.x     Document Type: Article

References (12)

1. 1 McCaw R, Moaven L, Locarnini SA, Bowden DS. Hepatitis C virus genotypes in Australia. J. Viral Hepatitis 1997; 4: 351-7.
2. 2 Seeff L. Natural history of hepatitis C. Hepatology 1997; 26: S21-8.
3. 3 Crofts N, Jolley D, Kaldor J, van Beek I, Wodak A. Epidemiology of hepatitis C virus infection among injecting drug users in Australia. J. Epidemiol. Community Health 1997; 51: 692-7.
4. 4 MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: Rates, routes and cofactors. Epidemiol. Rev. 1996; 18: 137-48.
5. 5 Gordon SC, Elloway RS, Long JC, Dmuchowski CF. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. IDU. Hepatology 1993; 18: 1338-43.
6. 6 Lopez-Morante A, Saez-Royuela F, Echevarria C et al. Influence of the transmission route and disease duration in the histopathology of chronic hepatitis C. A study of 101 patients. Eur. J. Gastroenterol. Hepatol. 1998; 10: 15-19.
7. 7 Lok AS, Ma OC, Chan TM et al. Overestimation of the prevalence of antibody to hepatitis C virus in retrospective studies on stored sera. Hepatology 1991; 14: 756-62.
8. 8 Irving WL, Neal KR, Underwood JC, Simmonds PN, James V. Chronic hepatitis in United Kingdom blood donors infected with hepatitis C virus. BMJ 1994; 308: 695-6.
9. 9 Bruno S, Rossi S, Petroni ML, Villa E, Zuin M, Podda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C virus. BMJ 1994; 308: 697.
10. 10 Healey CJ, Chapman RW, Fleming KA. Liver histology in hepatitis C infection: A comparison between patients with persistently normal or abnormal transaminases. Gut 1995; 37: 274-8.
11. 11 Haber MM, West AB, Haber AD, Reuben A. Relationship of aminotransferases to liver histological status in chronic hepatitis. Am. J. Gastroenterol. 1995; 90: 1250-7.
12. 12 National Health and Medical Research Council. A Strategy for the Detection and Management of Hepatitis C in Australia. Canberra: Australian Government Publishing Service, 1997.